TERT and hepatocellular carcinoma: For instance, telomerase reverse transcriptase (TERT) promoter mutations are presented in 25% of dysplastic nodules, increased in early HCC (61%) and remained stable in progressed and advanced HCC [30], which suggests that genetic instability might be an early hallmark in hepatocarcinogenesis.